CIBC Asset Management Inc Has $993,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

CIBC Asset Management Inc lowered its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 1.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 106,423 shares of the pharmacy operator’s stock after selling 1,863 shares during the quarter. CIBC Asset Management Inc’s holdings in Walgreens Boots Alliance were worth $993,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Sanctuary Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 10.5% in the fourth quarter. Sanctuary Advisors LLC now owns 51,209 shares of the pharmacy operator’s stock valued at $478,000 after buying an additional 4,876 shares during the period. Sheaff Brock Investment Advisors LLC increased its stake in shares of Walgreens Boots Alliance by 12.6% in the fourth quarter. Sheaff Brock Investment Advisors LLC now owns 27,524 shares of the pharmacy operator’s stock valued at $257,000 after buying an additional 3,085 shares during the period. Secured Retirement Advisors LLC acquired a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $99,000. Vontobel Holding Ltd. increased its stake in shares of Walgreens Boots Alliance by 131.2% in the fourth quarter. Vontobel Holding Ltd. now owns 321,880 shares of the pharmacy operator’s stock valued at $3,003,000 after buying an additional 182,644 shares during the period. Finally, Ingalls & Snyder LLC increased its stake in shares of Walgreens Boots Alliance by 13.6% in the fourth quarter. Ingalls & Snyder LLC now owns 338,779 shares of the pharmacy operator’s stock valued at $3,161,000 after buying an additional 40,570 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $10.16 on Friday. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $22.05. The business’s fifty day moving average is $10.37 and its 200 day moving average is $9.70. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The stock has a market cap of $8.78 billion, a P/E ratio of -0.99, a P/E/G ratio of 1.31 and a beta of 0.65.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same period last year, the business earned $0.66 EPS. The business’s revenue was up 7.6% on a year-over-year basis. Sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have weighed in on WBA. Truist Financial decreased their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Evercore ISI increased their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a research report on Monday, January 13th. Royal Bank of Canada increased their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Finally, Bank of America raised their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $12.63.

Check Out Our Latest Analysis on WBA

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.